Breadcrumb BRISTOL MYERS SQUIBB EMPLEADOS RIDE PARA LOS PACIENTES DE CÁNCER Continent 2 Continent 4 Cancer Ride en América Latina 2023 Bristol Myers Squibb extiende su inveterado compromiso por la investigación sobre el cáncer a través de su Continent 2 Continent 4 Cancer Ride en América Latina. Go to section Spanish English El recorrido en bicicleta recaudará fondos para las organizaciones latinoamericanas de lucha contra el cáncer miembros de la UICC Del 2 al 13 de diciembre, los empleados de Bristol Myers Squibb participarán en el evento 'Continent 2 Continent 4 Cancer' (C2C4C), recorriendo casi 1.500 km a través de Chile. Su objetivo es recaudar fondos para las organizaciones latinoamericanas de lucha contra el cáncer que son miembros de la UICC. Los ciclistas llevan 5 meses entrenándose y pedalean por sus cercanos afectados de cáncer. Desde 2022, se han donado más de 125.000 dólares a organizaciones benéficas de América Latina a través del recorrido C2C4C. El C2C4C inaugural se celebró hace diez años en los Estados Unidos con el nombre de "Coast 2 Coast 4 Cancer". Los ciclistas de Europa se unieron al esfuerzo en 2016 para el "Country 2 Country 4 Cancer", Japón en 2021 y América Latina en 2022 para el "Continent 2 Continent 4 Cancer". C2C4C se ha convertido en una tradición establecida y una ocasión importante en Bristol Myers Squibb, con más de 14 millones de dólares donados a nivel mundial para la investigación del cáncer al día de hoy. ¿Quiénes son los ciclistas? Los participantes en el desafío C2C4C en América Latina son ciclistas novatos que se han comprometido a realizar cinco meses de entrenamiento intensivo para completar su segmento de tres días de ruta. Este año son más de 55 los empleados que pedalean en América Latina y su motivación para participar y avanzar en la investigación contra el cáncer es personal. Algunos pedalean en honor de quienes han perdido la vida a causa del cáncer o luchan actualmente contra la enfermedad. Otros han sufrido ellos mismos un diagnóstico de cáncer. Este año, el recorrido será más plural e inclusivo que nunca, ya que participarán empleados de siete países: Argentina, Brasil, Chile, Colombia, México, Perú y Estados Unidos. Los empleados de Brasil participarán por primera vez. Juntos, sus kilómetros crearán más recuerdos para los enfermos de cáncer y sus queridos. Acerca de Bristol Myers Squibb Bristol Myers Squibb es una compañía biofarmacéutica global cuya misión es descubrir, desarrollar y suministrar medicamentos innovadores que ayuden a los pacientes a vencer enfermedades graves. Para más información sobre Bristol Myers Squibb, visítenos en BMS.com o síganos en LinkedIn, Twitter, YouTube, Facebook y Instagram. Por qué recaudar fondos para organizaciones contra el cáncer El cáncer se encuentra entre las principales causas de muerte en todo el mundo. Cada año, hay 18,1 millones de casos nuevos y 9,6 millones de muertes relacionadas con el cáncer en todo el mundo, y estas cifras van en aumento. Esta es la razón por la que Bristol Myers Squibb ha elegido apoyar a la UICC y a sus miembros en su misión de reducir la carga global del cáncer e integrar el control del cáncer en la agenda mundial de salud y desarrollo. Anime a sus colegas, familiares y amigos a donar, ya que el cáncer nos afecta a todos. Cada equipo monta y recauda fondos para los miembros de la UICC. Cómo puede apoyar la iniciativa C2C4C en América Latina Haga clic en la organización benéfica de su país para apoyar y donar a una organización local de pacientes con cáncer. Las donaciones están abiertas a partir del 1 de septiembre de 2023. Segmento Países Fechas Equipos Rutas Miembro de la UICC apoyado 1 Diciembre 2-4 Equipo de Chile, Colombia & Perú De Pucón, Chile a Puerto Varas, Chile Chile: Fundación Chile sin CáncerColombia: Instituto Nacional de Cancerología de Colombia Perú: ESPERANTRA 2 Diciembre 5-7 Equipo de México De Puerto Varas, Chile a Pucón, Chile Asociación Mexicana de Lucha Contra el Cáncer A.C. 3 Diciembre 8-10 Equipo de Brasil De Pucón, Chile a Puerto Varas, Chile Fundação Antonio Prudente A. C. Camargo Cancer Center 4 Diciembre 11-13 Equipo de Argentina De Puerto Varas, Chile a Pucón, Chile Liga Argentina de Lucha Contra el Cáncer (LALCEC) "Continent 2 Continent 4 Cancer representa verdaderamente el enfoque de Bristol Myers Squibb en lo crítico que es evolucionar la forma en que se trata el cáncer y la experiencia de los pacientes y cuidadores. Por segundo año consecutivo, la ruta en bicicleta C2C4C cruzará Chile y representa una experiencia que cambiará la vida de quienes se unan a ella y de quienes presencien la intensa preparación física, el inspirador compromiso y el viaje emocional de los ciclistas. Esperamos enorgullecer a organizaciones apoyadas miembros de la UICC y a nuestros empleados." Emma Charles, Vicepresidenta Senior, Intercontinental About the ride From 2 to 13 December, Bristol Myers Squibb employees will participate in the ‘Continent 2 Continent 4 Cancer’ (C2C4C) event, riding nearly 1,500 km through Chile. Their goal is to raise funds for Latin American cancer organisations that are members of the UICC. The riders have been training for 5 months and are cycling for loved ones affected by cancer. Since 2022, more than USD 125,000 have been donated to charitable organisations in Latin America via the C2C4C ride. The inaugural C2C4C ride was held ten years ago in the US as the ‘Coast 2 Coast 4 Cancer’. Riders in Europe joined the effort in 2016 for the ‘Country 2 Country 4 Cancer’, Japan in 2021 and Latin America in 2022 as the Continent 2 Continent 4 Cancer. C2C4C has become an established tradition and significant occasion at Bristol Myers Squibb, with more than USD 14 million donated globally for cancer research to date. Who are the riders? The participants in the C2C4C ride in Latin America are novice riders who have committed themselves to five months of intensive training to complete their three-day segment of the ride. There are more than 55 employees cycling in Latin America this year and their motivation to participate and advance cancer research is personal. Some are riding in honour of those who have lost their lives to cancer or are currently battling the disease. Others have experienced a cancer diagnosis themselves. This year, the ride will be more diverse and inclusive than ever, with employees from seven participating countries: Argentina, Brazil, Chile, Colombia, Mexico, Peru and the United States. Employees from Brazil will be participating in the ride for the first time. Together, their miles will make more memories for cancer patients and their loved ones. About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram. Why raise funds for cancer organisations? Cancer is among the leading causes of death worldwide. Each year, there are 18.1 million new cases and 9.6 million cancer-related deaths worldwide, and these numbers are growing. This is why Bristol Myers Squibb has chosen to support the UICC and its members in their mission to reduce the global cancer burden and integrate cancer control into the world health and development agenda. Encourage your colleagues, families and friends to donate, as cancer affects us all. Each team rides and raises funds for members of the UICC. How you can support the C2C4C initiative in Latin America? Click on the charity in your country to support and donate to a local cancer patient organisation. Donations are open as of 1 September 2023. Leg Countries Dates Teams Route Charity Partner 1 December 2-4 Chile, Colombia & Peru From Pucón, Chile to Puerto Varas, Chile Chile: Fundación Chile sin CáncerColombia: Instituto Nacional de Cancerología de Colombia Peru: ESPERANTRA 2 December 5-7 Mexico From Puerto Varas, Chile to Pucón, Chile Asociación Mexicana de Lucha Contra el Cáncer A.C. 3 December 8-10 Brazil From Pucón, Chile to Puerto Varas, Chile Fundação Antonio Prudente A. C. Camargo Cancer Center 4 December 11-13 Argentina From Puerto Varas, Chile to Pucón, Chile Liga Argentina de Lucha Contra el Cáncer (LALCEC) "Continent 2 Continent 4 Cancer truly represents Bristol Myers Squibb's laser focus on how critical it is to evolve the way cancer is treated and the experience of patients and caregivers. For the second year, the C2C4C ride will span through Chile, representing a life-changing experience for those who join and for those who witness the intense physical preparation, inspiring commitment and emotional journey of the riders. We hope to make our UICC member supported organisations and employees proud." Emma Charles, Senior Vice President, Intercontinental Ediciones anteriores/Previous editions Continued support for UICC members despite C2C4C cancellation Read more Bristol-Myers Squibb team completes fundraising ride across Europe Read more 95 Bristol-Myers Squibb cyclists set off on a 3,600km journey across Europe for cancer research Read more Bristol-Myers Squibb Employees Cycle for Cancer Research By: Zach Stowlow Read more Bristol-Myers Squibb employees rode over 3,600 km across Europe for cancer patients Read more Bristol-Myers Squibb employees raise funds for UICC members Read more Tags C2C4C Bristol-Myers Squibb Country 2 Country 4 Cancer Ride Last update Wednesday 13 September 2023 Share this page
"Continent 2 Continent 4 Cancer representa verdaderamente el enfoque de Bristol Myers Squibb en lo crítico que es evolucionar la forma en que se trata el cáncer y la experiencia de los pacientes y cuidadores. Por segundo año consecutivo, la ruta en bicicleta C2C4C cruzará Chile y representa una experiencia que cambiará la vida de quienes se unan a ella y de quienes presencien la intensa preparación física, el inspirador compromiso y el viaje emocional de los ciclistas. Esperamos enorgullecer a organizaciones apoyadas miembros de la UICC y a nuestros empleados." Emma Charles, Vicepresidenta Senior, Intercontinental About the ride From 2 to 13 December, Bristol Myers Squibb employees will participate in the ‘Continent 2 Continent 4 Cancer’ (C2C4C) event, riding nearly 1,500 km through Chile. Their goal is to raise funds for Latin American cancer organisations that are members of the UICC. The riders have been training for 5 months and are cycling for loved ones affected by cancer. Since 2022, more than USD 125,000 have been donated to charitable organisations in Latin America via the C2C4C ride. The inaugural C2C4C ride was held ten years ago in the US as the ‘Coast 2 Coast 4 Cancer’. Riders in Europe joined the effort in 2016 for the ‘Country 2 Country 4 Cancer’, Japan in 2021 and Latin America in 2022 as the Continent 2 Continent 4 Cancer. C2C4C has become an established tradition and significant occasion at Bristol Myers Squibb, with more than USD 14 million donated globally for cancer research to date. Who are the riders? The participants in the C2C4C ride in Latin America are novice riders who have committed themselves to five months of intensive training to complete their three-day segment of the ride. There are more than 55 employees cycling in Latin America this year and their motivation to participate and advance cancer research is personal. Some are riding in honour of those who have lost their lives to cancer or are currently battling the disease. Others have experienced a cancer diagnosis themselves. This year, the ride will be more diverse and inclusive than ever, with employees from seven participating countries: Argentina, Brazil, Chile, Colombia, Mexico, Peru and the United States. Employees from Brazil will be participating in the ride for the first time. Together, their miles will make more memories for cancer patients and their loved ones. About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram. Why raise funds for cancer organisations? Cancer is among the leading causes of death worldwide. Each year, there are 18.1 million new cases and 9.6 million cancer-related deaths worldwide, and these numbers are growing. This is why Bristol Myers Squibb has chosen to support the UICC and its members in their mission to reduce the global cancer burden and integrate cancer control into the world health and development agenda. Encourage your colleagues, families and friends to donate, as cancer affects us all. Each team rides and raises funds for members of the UICC. How you can support the C2C4C initiative in Latin America? Click on the charity in your country to support and donate to a local cancer patient organisation. Donations are open as of 1 September 2023. Leg Countries Dates Teams Route Charity Partner 1 December 2-4 Chile, Colombia & Peru From Pucón, Chile to Puerto Varas, Chile Chile: Fundación Chile sin CáncerColombia: Instituto Nacional de Cancerología de Colombia Peru: ESPERANTRA 2 December 5-7 Mexico From Puerto Varas, Chile to Pucón, Chile Asociación Mexicana de Lucha Contra el Cáncer A.C. 3 December 8-10 Brazil From Pucón, Chile to Puerto Varas, Chile Fundação Antonio Prudente A. C. Camargo Cancer Center 4 December 11-13 Argentina From Puerto Varas, Chile to Pucón, Chile Liga Argentina de Lucha Contra el Cáncer (LALCEC) "Continent 2 Continent 4 Cancer truly represents Bristol Myers Squibb's laser focus on how critical it is to evolve the way cancer is treated and the experience of patients and caregivers. For the second year, the C2C4C ride will span through Chile, representing a life-changing experience for those who join and for those who witness the intense physical preparation, inspiring commitment and emotional journey of the riders. We hope to make our UICC member supported organisations and employees proud." Emma Charles, Senior Vice President, Intercontinental Ediciones anteriores/Previous editions Continued support for UICC members despite C2C4C cancellation Read more Bristol-Myers Squibb team completes fundraising ride across Europe Read more 95 Bristol-Myers Squibb cyclists set off on a 3,600km journey across Europe for cancer research Read more Bristol-Myers Squibb Employees Cycle for Cancer Research By: Zach Stowlow Read more Bristol-Myers Squibb employees rode over 3,600 km across Europe for cancer patients Read more Bristol-Myers Squibb employees raise funds for UICC members Read more Tags C2C4C Bristol-Myers Squibb Country 2 Country 4 Cancer Ride Last update Wednesday 13 September 2023 Share this page
"Continent 2 Continent 4 Cancer truly represents Bristol Myers Squibb's laser focus on how critical it is to evolve the way cancer is treated and the experience of patients and caregivers. For the second year, the C2C4C ride will span through Chile, representing a life-changing experience for those who join and for those who witness the intense physical preparation, inspiring commitment and emotional journey of the riders. We hope to make our UICC member supported organisations and employees proud." Emma Charles, Senior Vice President, Intercontinental Ediciones anteriores/Previous editions Continued support for UICC members despite C2C4C cancellation Read more Bristol-Myers Squibb team completes fundraising ride across Europe Read more 95 Bristol-Myers Squibb cyclists set off on a 3,600km journey across Europe for cancer research Read more Bristol-Myers Squibb Employees Cycle for Cancer Research By: Zach Stowlow Read more Bristol-Myers Squibb employees rode over 3,600 km across Europe for cancer patients Read more Bristol-Myers Squibb employees raise funds for UICC members Read more Tags C2C4C Bristol-Myers Squibb Country 2 Country 4 Cancer Ride Last update Wednesday 13 September 2023 Share this page
